Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2007
08/01/2007EP1313715B1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
08/01/2007EP1294714B1 Thrombin receptor antagonists
08/01/2007EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents
08/01/2007CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders
08/01/2007CN1329374C Compound as CCR5 agonist
08/01/2007CN101010319A Indole derivatives, their manufacture and use as pharmaceutical agents
08/01/2007CN101010318A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
08/01/2007CN101010317A 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
08/01/2007CN101010316A Compounds useful for inhibiting CHK1
08/01/2007CN101010315A Substituted pyrazolyl urea derivatives useful in the treatment of cancer
08/01/2007CN101010301A 5-HT7 receptor antagonosts
08/01/2007CN101010299A Six-membered heterocycles useful as serine protease inhibitors
08/01/2007CN101010281A Alternative synthesis of renin inhibitors and intermediates thereof
08/01/2007CN101007804A 1,3-benzodioxole-2,2-dicarboxylic acid derivatives and their preparation method and medicinal uses
08/01/2007CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/2007
07/31/2007USRE39754 Benzamide derivatives and pharmaceutical compositions containing same
07/31/2007US7250518 treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructuive pulmonary disease
07/31/2007US7250444 Pyrrole-based HMG-CoA reductase inhibitors
07/31/2007US7250443 Pyrrole based inhibitors of glycogen synthase kinase 3
07/31/2007US7250442 glucocorticoid, androgen, mineralcorticoid, estrogen and progesterone receptor modulators such as 3,3-Bis-(4-hydroxy-3,5-dimethyl-phenyl)-1-(4-methoxy-benzyl)-1,3-dihydro-indol-2-one, used for treating congestive heart failure
07/31/2007US7250414 Antihistamines; bronchodilator agents; respiratory system disorders; 2-{(S)-1-[4-(4-aminophenyl)butyl]pyrrolidin-3-yl}-2,2-diphenylacetamide; chemical synthesis; Bioassay of testing the compound on the biological sample
07/31/2007CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
07/31/2007CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
07/26/2007WO2007083732A1 Optical recording medium and azo metal chelate compound
07/26/2007WO2007083017A2 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
07/26/2007WO2007082910A1 Dicarbonylic compounds with antibacterial activity
07/26/2007WO2007082907A1 Substituted 4-phenylpiperidines
07/26/2007WO2007082873A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
07/26/2007WO2007082805A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
07/26/2007WO2007082434A1 Quinazoline derivatives,preparation methods and uses thereof
07/26/2007US20070173536 Crystalline forms of zolmitriptan
07/26/2007US20070173535 Oxadiazoles having antiproliferative activity
07/26/2007US20070173501 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
07/26/2007US20070173500 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
07/26/2007US20070173498 Melanin concentrating hormone antagonist
07/26/2007US20070173494 Diaza heterocyclic sulfonamide derivatives and their uses
07/26/2007US20070173491 Substituted lactams as inhibitors of Abeta protein production
07/26/2007US20070173489 antagonists of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex, exhibit anticoagulant effect and are suitable for the therapy and prophylaxis of cardiovascular disorders
07/26/2007CA2637565A1 Cannibinoid receptor modulators
07/26/2007CA2637459A1 Substituted 4-phenylpiperidines
07/26/2007CA2637385A1 Compounds for the treatment of inflammatory disorders
07/26/2007CA2637057A1 Diaryl piperidines as cb1 modulators
07/26/2007CA2637052A1 Dicarbonylic compounds with antibacterial activity
07/26/2007CA2636916A1 Methods for treating hepatitis c
07/26/2007CA2636905A1 Methods for treating hepatitis c
07/26/2007CA2636824A1 Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
07/26/2007CA2630273A1 Heterocyclylalkyl derivatives as inhibitors of histone deacetylase
07/25/2007EP1810969A1 Aryloxy-substituted benzimidazole derivatives
07/25/2007EP1809622A1 Inhibitors of the interaction between mdm2 and p53
07/25/2007EP1809620A1 Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
07/25/2007EP1809619A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
07/25/2007EP1809607A1 Sulfonyl benzimidazole derivatives
07/25/2007EP1809290A2 Pyrimidine derivatives as ion channel modulators and methods of use
07/25/2007EP1809280A2 Mitotic kinesin inhibitors and methods of use thereof
07/25/2007EP1581207A4 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
07/25/2007EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
07/25/2007EP1389190B1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
07/25/2007CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
07/25/2007CN101006084A 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof
07/25/2007CN101006083A Dpp-iv inhibitors
07/25/2007CN101006082A Histamine H3 receptor agents, preparation and therapeutic uses
07/25/2007CN101006078A Gonadotropin releasing hormone receptor antagonists
07/25/2007CN101006074A Piperidine derivatives as NK1 antagonists
07/25/2007CN101006058A Chemical compounds I
07/25/2007CN101005836A Novel indazole carboxamides and their use
07/25/2007CN101003517A Cyclic compound, process for producing the same, and pest control agent
07/24/2007US7247738 Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
07/24/2007US7247725 Gamma-aminoamide modulators of chemokine receptor activity
07/24/2007US7247649 e.g 1-[4-(4-{2-[2-(E)-(4-Chloro-2-fluoro-phenyl)-vinyl]-oxazol-4-ylmethoxy}-phenyl)-butyl]-1H-[1,2,3]triazole; inhibitors of the HER (human epidermal growth factor receptors)-signalling pathway; antiprolirative; cancer
07/24/2007US7247637 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life
07/24/2007US7247635 Pyrazole derivative
07/24/2007US7247633 Pyrimidine compounds and their use
07/24/2007US7247628 Cannabinoid receptor ligands and uses thereof
07/24/2007US7247627 non-hygroscopic, crystalline anhydrous maleate salt of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene) methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
07/24/2007CA2238274C Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
07/19/2007WO2007080882A1 Oxazolone derivative
07/19/2007WO2007080542A1 Novel thiophene derivatives as s1p1/edg1 receptor agonists
07/19/2007WO2007080382A1 Morpholino pyrimidine derivatives and their use in therapy
07/19/2007WO2007079931A1 Substituted oxadiazole derivatives and their use as opioid receptor ligands
07/19/2007WO2007079928A1 Substituted oxazole derivatives with an analgesic action
07/19/2007WO2007079653A1 OPTICALLY PURE α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOLE-1-ETHANOL DERIVATIVES
07/19/2007WO2007064931A3 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
07/19/2007WO2007058338A3 Oxazole compound and pharmaceutical composition
07/19/2007WO2007054453A3 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
07/19/2007WO2006105372A3 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
07/19/2007US20070167631 Novel herbicides
07/19/2007US20070167621 Substituted pyrimidinones
07/19/2007US20070167503 Substituted benzoxazoles as estrogenic agents
07/19/2007US20070167499 Biaryl linked hydroxamates: preparation and pharmaceutical applications
07/19/2007US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof
07/19/2007US20070167483 Phenylalanine Enamide Derivatives
07/19/2007US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder
07/19/2007US20070167456 Mercaptoimidazoles as ccr2 receptor antagonists
07/19/2007US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES
07/19/2007US20070167449 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors
07/19/2007US20070167448 Derivatives of sulphonamides, their preparation and use as medicaments
07/19/2007US20070167447 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
07/19/2007US20070167444 Benzamide derivative or salt thereof
07/19/2007US20070167443 Substituted quinolones and methods of use
07/19/2007US20070167442 Such as 1-(1-{3-[4-(ethylsulfonyl)piperazin-1-yl]-3-phenylpropyl}piperidin-4-yl)-5-(methylsulfonyl)-1H-benzimidazole; reductive amination